Asacol® 800 mg tablets (mesalazine) is first-line treatment for mild to moderate ulcerative colitis (UC).
Asacol is indicated for the treatment of the inflamed lining of the large bowel (colonic and rectal mucosa) and is the first-line treatment for mild to moderate ulcerative colitis.
The World’s Leading Mesalazine
Asacol contains mesalazine and is available as tablets in 400 and 800mg strengths.
Available in clinics and all major retail pharmacies.
Key Features & Benefits
Asacol 1600 mg (mesalazine) incorporates the modern OPTICORE technology and is indicated for the treatment of mild to moderate UC. Asacol 1600 is currently available in Denmark, Iceland and Norway under the brand name Asacol and in the Netherlands under the brand name Yaldigo.
Asacol 1600: Important information on ASACOL™ 1600 mg and its use can be found in the summary of product characteristics (SmPC)